Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure.
Kumar A, Arora A, Choudhury A, Arora V, Rela M, Jothimani DK, Mahtab MA, Devarbhavi H, Eapen CE, Goel A, Yaghi C, Ning Q, Chen T, Jia J, Zhongping D, Hamid SS, Butt AS, Jafri W, Shukla A, Tan SS, Kim DJ, Saraya A, Hu J, Sood A, Goyal O, Midha V, Pati GK, Singh A, Lee GH, Treeprasertsuk S, Thanapirom K, Mandot A, Maghade R, Lesmana RC, Ghazinyan H, Mohan Prasad VG, Dokmeci AK, Sollano JD, Abbas Z, Shrestha A, Lau GK, Payawal DA, Shiha GE, Duseja A, Taneja S, Verma N, Rao PN, Kulkarni AV, Karim F, Saraswat VA, Alam S, Chowdhury D, Kedarisetty CK, Saigal S, Sharma P, Yattoo GN, Koshy A, Patwa AK, Elbasiony M, Rathi PM, Maharshi S, Dayal VM, Jha AK, Kalista KF, Gani RA, Yuen MF, Singh V, Sargsyan VA, Huang CH, Mukewar SS, Xin S, Rajaram RB, Panackel C, Dadhich S, Sachdeva S, Kumar A, Behera S, Kamani L, Saithanyamurthi HV, Prasad B, Sarin SK; APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party.
Kumar A, et al. Among authors: pati gk.
Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002951. Online ahead of print.
Am J Gastroenterol. 2024.
PMID: 39016385
